(Unaudited data)

Cumulative Activity as of the end of june 2020














In thousands of euros20192020Variation at current exchange ratesVariation at constant exchange rates
France151 357126 323-16,5%-16,5%
Europe (excluding France)55 33054 485-1,5%-0,8%
North America40 66161 365+50,9%+47,4%
Other countries9 37011 460+22,3%+35,6%
Group total256 718253 633-1,2%-1,1%

 

In thousands of euros20192020Variation at current exchange ratesVariation at constant exchange rates
Non-proprietary Homeopathic Medicines133 214110 055-17,4%-17,5%
OTC Specialties122 716142 917+16,5%+16,8%
Other788660-16,2%-15,3%
Group total256 718253 633-1,2%-1,1%

Activity by quarter (variation at current exchange rates)

In thousands of euros1st quarter2d quarter
 20192020Var. 20/1920192020Var. 20/19
France83 44072 820-12,7%67 91753 503-21,2%
Europe (excluding France)31 77937 581+18,3%23 55116 904-28,2%
North America23 58040 272+70,8%17 08121 094+23,5%
Other countries4 5165 960+32,0%4 8545 499+13,3%
Group total143 315156 633+9,3%113 40396 999-14,5%

 

In thousands of euros1st quarter2d quarter
 20192020Var. 20/1920192020Var. 20/19
Non-proprietary Homeopathic Medicines69 06761 722-10,6%64 14748 334-24,7%
OTC Specialties73 84594 619+28,1%48 87148 298-1,2%
Other403292-27,3%385367-4,6%
Group total143 315156 633+9,3%113 40396 999-14,5%

Sales growth

Sales in the second quarter of 2020 were down 14.5% versus 2019. In an already delicate context, the decline in sales in France worsened (down 21.2% vs. a drop of 12.7% in the first quarter) following decreased doctors' appointments and pharmacy visits during the health crisis. This impacted different countries in different ways: sales in Europe were down 28.2%, mainly in Russia and Italy, while sales grew 23.5% in North America.

Over the first half, sales were down 1.2%, as a result of two contrasting developments:

  • A 16.5% decline in business in France in non-proprietary medicines (down 21.0%) and specialties (down 6.6%)
  • International sales growth of 20.8%, mainly in North America

Furthermore, in France, we have produced over 50,000 liters of hydro-alcoholic solution, for which marketing authorization has been extended until the end of this year.

News

Following the significant drop in business in France, a reorganization plan was announced on 11 March. Given that meetings to negotiate with staff representatives could not take place during the lockdown, they began at the start of June and will continue until 14 October this year. A provision for the cost of this plan will be recorded in the first half financial statements, to be published on 9 September.

Despite the ongoing global health crisis, we have managed to maintain our production and distribution businesses, both in France and abroad, thanks to the commitment of all our employees. Administrative work was performed under remote working arrangements during the lockdown, and only commercial activities were temporarily impacted.

Outlook

Global business levels looking forward will depend on how the global health and economic situation progresses.

We believe that sales in France will continue to be impacted over the second half by the government's decision to delist non-proprietary medicines from French health insurance from 1st January 2021.

As such, we expect to see a decrease in sales and earnings in 2020.

We remain determined to continue our efforts to maintain the reimbursement of homeopathic medicines, reflecting the demand of the millions of patients who use them with satisfaction.

Laboratoires BOIRON

Our next update:
September 9, 2020: at market close, publication of 2020 half-year results.
Person responsible for financial information: Valérie Lorentz-Poinsot.
Contact for financial information: Fabrice Rey.
Investor relations: +33 (0) 4.78.45.63.43 - e-mail: boironfinances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA
The group's financial information and the glossary are online at: www.boironfinance.com


Cette publication dispose du service "Actusnews SECURITY MASTER".
- SECURITY MASTER Key : lG2flchvk5qYlmyaaMqam5WXaJmSkmOaZWPHlpNva8iZm3FomJhhacqYZm9lmGdu
- Pour contrôler cette clé : https://www.security-master-key.com.

Information réglementée :
Informations privilégiées :
- Communiqué sur comptes, résultats

Communiqué intégral et original au format PDF : https://www.actusnews.com/news/64328-boi-160720-ca-s1-2020-gb.pdf

© Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com


© 2020 ActusNews